TACSTD2 and cancer: The complete absence of associations between TROP2/EpCAM expression – even if measured with a highly quantitative method - and histopathological parameters of cancer aggressiveness or clinical outcome in muscle-invasive urothelial carcinoma is also consistent with RNA data from The Cancer Genome Atlas (TCGA) (https://www.cancer.gov/tcga).